Journal of Experimental Botany, Vol. 41, No. 225 (April 1990), pp. 481-488 (8 pages) The patterns of substrate degradation by purified pectate lyase (PGL) (E.C. 4.2.2.2) from Erwinia carotovora and ...
A research team has unraveled the three-dimensional structure and molecular mechanism of ATP citrate lyase (ACLY). This is a central metabolic enzyme -- a protein that accelerates chemical reactions - ...
Non-alcoholic fatty liver disease (NAFLD) affects over 25% of Canadians and is a leading risk factor for the development of type 2 diabetes, cardiovascular disease and liver transplant yet despite its ...
Activity of VT-464, a selective CYP17 lyase inhibitor, in the LNCaP prostate cancer xenograft model.
Evaluation of circulating tumor cells (CTCs) enumeration and 18F-Choline positron emission tomography/computed tomography (FCH PET/CT) as early efficacy response biomarkers in metastatic ...
Clinical activity of enzalutamide against metastatic castration-resistant prostate cancer (mCRPC) in patients who have progressed on abiraterone acetate: The Princess Margaret experience. This is an ...
Esperion Therapeutics Inc. has described ATP citrate lyase (ACLY) inhibitors reported to be useful for the treatment of cancer, nonalcoholic or metabolic dysfunction-associated steatohepatitis ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today published research in Nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results